ENDRA Life Sciences (NDRA) Competitors $4.54 -0.75 (-14.18%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends NDRA vs. ICU, PAVM, STRR, LUCY, QTI, TTOO, PETV, GCTK, CUTR, and INBSShould you be buying ENDRA Life Sciences stock or one of its competitors? The main competitors of ENDRA Life Sciences include SeaStar Medical (ICU), PAVmed (PAVM), Star Equity (STRR), Innovative Eyewear (LUCY), QT Imaging (QTI), T2 Biosystems (TTOO), PetVivo (PETV), GlucoTrack (GCTK), Cutera (CUTR), and Intelligent Bio Solutions (INBS). These companies are all part of the "medical equipment" industry. ENDRA Life Sciences vs. SeaStar Medical PAVmed Star Equity Innovative Eyewear QT Imaging T2 Biosystems PetVivo GlucoTrack Cutera Intelligent Bio Solutions ENDRA Life Sciences (NASDAQ:NDRA) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, community ranking, analyst recommendations, earnings and valuation. Does the media prefer NDRA or ICU? In the previous week, SeaStar Medical had 4 more articles in the media than ENDRA Life Sciences. MarketBeat recorded 9 mentions for SeaStar Medical and 5 mentions for ENDRA Life Sciences. ENDRA Life Sciences' average media sentiment score of 0.58 beat SeaStar Medical's score of 0.14 indicating that ENDRA Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ENDRA Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SeaStar Medical 0 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders have more ownership in NDRA or ICU? 1.2% of ENDRA Life Sciences shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 0.0% of ENDRA Life Sciences shares are held by insiders. Comparatively, 2.1% of SeaStar Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts recommend NDRA or ICU? ENDRA Life Sciences currently has a consensus price target of $700,000.00, suggesting a potential upside of 15,418,402.20%. Given ENDRA Life Sciences' stronger consensus rating and higher possible upside, research analysts clearly believe ENDRA Life Sciences is more favorable than SeaStar Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ENDRA Life Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00SeaStar Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor NDRA or ICU? ENDRA Life Sciences received 235 more outperform votes than SeaStar Medical when rated by MarketBeat users. However, 100.00% of users gave SeaStar Medical an outperform vote while only 62.77% of users gave ENDRA Life Sciences an outperform vote. CompanyUnderperformOutperformENDRA Life SciencesOutperform Votes23662.77% Underperform Votes14037.23% SeaStar MedicalOutperform Votes1100.00% Underperform VotesNo Votes Is NDRA or ICU more profitable? SeaStar Medical's return on equity of 0.00% beat ENDRA Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets ENDRA Life SciencesN/A -163.18% -128.68% SeaStar Medical N/A N/A -627.49% Which has preferable valuation and earnings, NDRA or ICU? SeaStar Medical is trading at a lower price-to-earnings ratio than ENDRA Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioENDRA Life SciencesN/AN/A-$10.06M-$901.15-0.01SeaStar MedicalN/AN/A-$26.23M-$11.63-0.19 Which has more volatility and risk, NDRA or ICU? ENDRA Life Sciences has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.08, indicating that its stock price is 208% less volatile than the S&P 500. SummaryENDRA Life Sciences beats SeaStar Medical on 9 of the 15 factors compared between the two stocks. Ad Genesis Gold GroupTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov Get ENDRA Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NDRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NDRA vs. The Competition Export to ExcelMetricENDRA Life SciencesElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.24M$3.61B$5.15B$8.74BDividend YieldN/A1.65%5.18%4.08%P/E Ratio-0.0111.4666.6713.57Price / SalesN/A99.251,276.8487.67Price / CashN/A46.1739.7035.24Price / Book0.003.806.475.93Net Income-$10.06M$92.21M$119.73M$225.73M7 Day Performance-25.08%-2.39%-5.13%-1.34%1 Month Performance-37.06%13.84%-2.71%1.15%1 Year Performance-99.99%26.34%31.08%24.02% ENDRA Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NDRAENDRA Life Sciences3.6817 of 5 stars$4.54-14.2%$700,000.00+15,418,402.2%-100.0%$2.24MN/A-0.0120Short Interest ↓News CoverageICUSeaStar Medical0.2625 of 5 stars$2.70+3.4%N/A-85.4%$11.78MN/A-0.142Short Interest ↑News CoverageGap UpPAVMPAVmed4.0577 of 5 stars$1.12+0.9%N/A-65.6%$11.66M$2.45M-0.1490News CoverageGap UpSTRRStar Equity2.1789 of 5 stars$3.50-2.5%N/A-32.5%$11.31M$47.15M-1.25171Upcoming EarningsNews CoverageLUCYInnovative Eyewear2.5958 of 5 stars$7.15-2.3%N/A-16.5%$11.23M$1.53M-0.659Earnings ReportShort Interest ↑Gap UpQTIQT ImagingN/A$0.51flatN/AN/A$10.85MN/A0.00N/AInsider BuyingShort Interest ↓News CoveragePositive NewsGap UpTTOOT2 Biosystems2.4604 of 5 stars$0.59+1.7%N/A-88.2%$10.38M$7.19M0.00180Short Interest ↑News CoverageGap DownHigh Trading VolumePETVPetVivoN/A$0.50-10.7%N/A-33.3%$10.25M$970,000.00-0.7720News CoverageGap DownGCTKGlucoTrack0.504 of 5 stars$1.41+2.2%N/A-66.1%$8.14MN/A-0.585Short Interest ↑News CoverageGap DownHigh Trading VolumeCUTRCutera1.4425 of 5 stars$0.39flatN/A-86.2%$7.82M$169.19M-0.06430Short Interest ↑INBSIntelligent Bio Solutions0.2419 of 5 stars$1.84+12.9%N/A-76.3%$7.82M$3.11M0.0010Short Interest ↑Positive NewsGap Up Related Companies and Tools Related Companies SeaStar Medical Competitors PAVmed Competitors Star Equity Competitors Innovative Eyewear Competitors QT Imaging Competitors T2 Biosystems Competitors PetVivo Competitors GlucoTrack Competitors Cutera Competitors Intelligent Bio Solutions Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NDRA) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ENDRA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NDRA Stock Alerts